TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 116 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $13,283,000 | +434.1% | 756,426 | +195.0% | 0.16% | +378.8% |
| Q2 2021 | $2,487,000 | -9.7% | 256,426 | 0.0% | 0.03% | -19.5% |
| Q1 2021 | $2,754,000 | -88.6% | 256,426 | -84.4% | 0.04% | -89.5% |
| Q4 2020 | $24,116,000 | +88.8% | 1,639,421 | +82.3% | 0.39% | +48.9% |
| Q3 2020 | $12,776,000 | – | 899,103 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 260,000 | $5,260,000 | 2.44% |
| Avoro Capital Advisors LLC | 160,697 | $3,234,000 | 1.24% |
| Private Capital Advisors, Inc. | 83,820 | $1,696,000 | 0.62% |
| Monashee Investment Management LLC | 25,000 | $506,000 | 0.32% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $1,922,000 | 0.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 226,064 | $4,573,000 | 0.15% |
| Spark Investment Management LLC | 36,700 | $745,000 | 0.10% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,121 | $589,000 | 0.04% |
| A.R.T. Advisors, LLC | 15,480 | $313,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 1,200 | $31,000 | 0.00% |